Simplex Trading’s Aethlon Medical AEMD Stock Holding History

Simplex Trading’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1	Closed	-$1K	–	9794
2022 Q2	$1K	Sell	1 -1	-50%	-$931	﹤0.01%	9509
2022 Q1	$2K	Sell	2 -20	-91%	-$23.9K	﹤0.01%	9805
2021 Q4	$32K	Buy	+22	New	+$50.1K	﹤0.01%	7796

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Simplex Trading's AEMD Position: Q4 2023 in Review

Simplex Trading sold out of Aethlon Medical (AEMD) in Q4 2023, closing a stake of 1 share.

Simplex Trading first reported a position in AEMD in Q4 2021 and held it in 8 quarters. The position peaked at $31K in Q4 2021. 10 funds tracked by Wall St. Rank hold AEMD as of Q4 2023.

Simplex Trading reported no remaining Aethlon Medical position as of Q4 2023 after selling out during the quarter.
Simplex Trading sold 1 Aethlon Medical share in Q4 2023.
Simplex Trading first reported a position in Aethlon Medical in Q4 2021 and held it in 8 quarters.
Simplex Trading's Aethlon Medical position peaked at $31K in Q4 2021.
10 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.